Associations between cytotoxic T lymphocyte-associated antigen-4 polymorphisms and serum tumor necrosis factor-α and interferon-γ levels in patients with chronic hepatitis B virus infection

Inflammation Research

Volumn 60, Issue 11, 2011, Pages 1071-1078

  Han, Qunying ^a   Duan, Shaoqiong ^a   Zhang, Guoyu ^a   Li, Zhu ^a   Li, Na ^a   Zhu, Qianqian ^a   Lv, Yi ^a   Chen, Jinghong ^a   Liu, Zhengwen ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

Chronic HBV infection; Cytotoxic T lymphocyte associated antigen 4; Genetic polymorphism; Interferon ; Tumor necrosis factor

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GAMMA INTERFERON; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4 GENE; DISEASE ACTIVITY; DISEASE ASSOCIATION; EXON; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENE FUNCTION; GENE IDENTIFICATION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HEPATITIS B; HUMAN; MAJOR CLINICAL STUDY; MALE; MOLECULAR PATHOLOGY; PROMOTER REGION; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REGULATOR GENE; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; ALLELES; CTLA-4 ANTIGEN; EXONS; FEMALE; GENOTYPE; HAPLOTYPES; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; INTERFERON-GAMMA; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 80855138073     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/s00011-011-0368-8     Document Type: Article

References (46)

1. D Ganem AM Prince 2004 Hepatitis B virus infection-natural history and clinical consequences N Engl J Med 350 1118 1129 15014185 10.1056/NEJMra031087 1:CAS:528:DC%2BD2cXitV2qurs%3D (Pubitemid 38298992)
2. PL Yang A Althage J Chung H Maier S Wieland M Isogawa, et al. 2010 Immune effectors required for hepatitis B virus clearance Proc Natl Acad Sci USA 107 798 802 20080755 10.1073/pnas.0913498107 1:CAS:528:DC%2BC3cXhtFCmsLw%3D
3. R Thimme S Wieland C Steiger J Ghrayeb KA Reimann RH Purcell, et al. 2003 CD8(+) T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection J Virol 77 68 76 12477811 10.1128/JVI.77.1.68-76. 2003 1:CAS:528:DC%2BD3sXkt1Sn (Pubitemid 36004947)
4. MK Maini C Boni CK Lee JR Larrubia S Reignat GS Ogg, et al. 2000 The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection J Exp Med 191 1269 1280 10770795 10.1084/jem.191.8.1269 1:CAS:528:DC%2BD3cXislSitLs%3D (Pubitemid 30227116)
5. A Bertoletti M Maini R Williams 2003 Role of hepatitis B virus specific cytotoxic T cells in liver damage and viral control Antiviral Res 60 61 66 14638399 10.1016/j.antiviral.2003.08.012 1:CAS:528:DC%2BD3sXpt1eqsr4%3D (Pubitemid 37452447)
6. B Rehermann 2003 Immune responses in hepatitis B virus infection Semin Liver Dis 23 21 38 12616448 10.1055/s-2003-37586 1:CAS:528:DC%2BD3sXisFamtrs%3D
7. LG Guidotti S Guilhot FV Chisari 1994 Interleukin-2 and alpha/beta interferon down-regulate hepatitis B virus gene expression in vivo by tumor necrosis factor-dependent and -independent pathways J Virol 68 1265 1270 8107192 1:CAS:528:DyaK2cXhvV2mu74%3D (Pubitemid 24065687)
8. CF Huang SS Lin YC Ho FL Chen CC Yang 2006 The immune response induced by hepatitis B virus principal antigens Cell Mol Immunol 3 97 106 16696896 1:CAS:528:DC%2BD28XlvVSqtb0%3D
9. CA Piccirillo EM Shevach 2001 Cutting edge: control of CD8+ T cell activation by CD4+ CD25+ immunoregulatory cells J Immunol 167 1137 1140 11466326 1:CAS:528:DC%2BD3MXls1WktL0%3D (Pubitemid 32703105)
10. EM Shevach RS McHugh CA Piccirillo AM Thornton 2001 Control of T-cell activation by CD4+ CD25+ suppressor T cells Immunol Rev 182 58 67 11722623 10.1034/j.1600-065X.2001.1820104.x 1:CAS:528:DC%2BD3MXpt1eisL8%3D (Pubitemid 33070207)
11. CY Lin MC Tsai CT Huang CW Hsu SC Tseng IF Tsai, et al. 2007 Liver injury is associated with enhanced regulatory T-cell activity in patients with chronic hepatitis B J Viral Hepat 14 503 511 17576392 10.1111/j.1365-2893.2006.00835.x (Pubitemid 46944473)
12. G Peng S Li W Wu Z Sun Y Chen Z Chen 2008 Circulating CD4+ CD25+ regulatory T cells correlate with chronic hepatitis B infection Immunology 123 57 65 17764450 10.1111/j.1365-2567.2007.02691.x 1:CAS:528:DC%2BD1cXnsFWjsg%3D%3D (Pubitemid 350255997)
13. JN Stoop RG van der Molen CC Baan LJ van der Laan EJ Kuipers JG Kusters, et al. 2005 Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection Hepatology 41 771 778 15791617 10.1002/hep.20649 1:CAS:528:DC%2BD2MXjsV2msLs%3D (Pubitemid 40462939)
14. BM Carreno F Bennett TA Chau V Ling D Luxenberg J Jussif, et al. 2000 CTLA-4 (CD152) can inhibit T cell activation by two different mechanisms depending on its level of cell surface expression J Immunol 165 1352 1356 10903737 1:STN:280:DC%2BD3cvgsFejtQ%3D%3D (Pubitemid 30604565)
15. DK Sojka A Hughson DJ Fowell 2009 CTLA-4 is required by CD4+CD25+ Treg to control CD4+ T-cell lymphopenia-induced proliferation Eur J Immunol 39 1544 1551 19462377 10.1002/eji.200838603 1:CAS:528:DC%2BD1MXntFCitLc%3D
16. MA Oosterwegel RJ Greenwald DA Mandelbrot RB Lorsbach AH Sharpe 1999 CTLA-4 and T cell activation Curr Opin Immunol 11 294 300 10375557 10.1016/S0952-7915(99)80047-8 1:CAS:528:DyaK1MXjvVKjtbc%3D (Pubitemid 29263957)
17. VK Kuchroo MP Das JA Brown AM Ranger SS Zamvil RA Sobel, et al. 1995 B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy Cell 80 707 718 7534215 10.1016/0092-8674(95)90349-6 1:CAS:528:DyaK2MXksVahs78%3D
18. JK Hegel K Knieke P Kolar SL Reiner MC Brunner-Weinzierl 2009 CD152 (CTLA-4) regulates effector functions of CD8+ T lymphocytes by repressing Eomesodermin Eur J Immunol 39 883 893 19224637 10.1002/eji.200838770 1:CAS:528:DC%2BD1MXktVaitr4%3D
19. P Pandiyan JK Hegel M Krueger D Quandt MC Brunner-Weinzierl 2007 High IFN-gamma production of individual CD8 T lymphocytes is controlled by CD152 (CTLA-4) J Immunol 178 2132 2140 17277117 1:CAS:528:DC%2BD2sXht1Cgurk%3D (Pubitemid 46233410)
20. MS Kuhns V Epshteyn RA Sobel JP Allison 2000 Cytotoxic T lymphocyte antigen-4 (CTLA-4) regulates the size, reactivity, and function of a primed pool of CD4+ T cells Proc Natl Acad Sci USA 97 12711 12716 11050166 10.1073/pnas.220423597 1:CAS:528:DC%2BD3cXotFynsb0%3D
21. A Ohta M Sekimoto M Sato T Koda S Nishimura Y Iwakura, et al. 2000 Indispensable role for TNF-alpha and IFN-gamma at the effector phase of liver injury mediated by Th1 cells specific to hepatitis B virus surface antigen J Immunol 165 956 961 10878371 1:CAS:528:DC%2BD3cXkvFWitro%3D (Pubitemid 30484764)
22. S Kasahara K Ando K Saito K Sekikawa H Ito T Ishikawa, et al. 2003 Lack of tumor necrosis factor alpha induces impaired proliferation of hepatitis B virus-specific cytotoxic T lymphocytes J Virol 77 2469 2476 12551985 10.1128/JVI.77.4.2469-2476.2003 1:CAS:528:DC%2BD3sXpvVGntQ%3D%3D (Pubitemid 36222771)
23. JN Stoop AM Woltman PJ Biesta JG Kusters EJ Kuipers HL Janssen, et al. 2007 Tumor necrosis factor alpha inhibits the suppressive effect of regulatory T cells on the hepatitis B virus-specific immune response Hepatology 46 699 705 17654744 10.1002/hep.21761 1:CAS:528:DC%2BD2sXhtFWhsrzF (Pubitemid 47436115)
24. L Malmgaard 2004 Induction and regulation of IFNs during viral infections J Interferon Cytokine Res 24 439 454 15320958 10.1089/1079990041689665 1:CAS:528:DC%2BD2cXms12jt74%3D (Pubitemid 39120592)
25. A Ligers N Teleshova T Masterman WX Huang J Hillert 2001 CTLA-4 gene expression is influenced by promoter and exon 1 polymorphisms Genes Immun 2 145 152 11426323 10.1038/sj.gene.6363752 1:CAS:528:DC%2BD3MXksVyisbc%3D (Pubitemid 33674879)
26. M Mäurer S Loserth A Kolb-Mäurer A Ponath S Wiese N Kruse, et al. 2002 A polymorphism in the human cytotoxic T-lymphocyte antigen 4 (CTLA4) gene (exon 1 +49) alters T-cell activation Immunogenetics 54 1 8 11976786 10.1007/s00251-002-0429-9 (Pubitemid 34492947)
27. XB Wang X Zhao R Giscombe AK Lefvert 2002 A CTLA-4 gene polymorphism at position -318 in the promoter region affects the expression of protein Genes Immun 3 233 234 12058260 10.1038/sj.gene.6363869 (Pubitemid 38961137)
28. CL Thio TL Mosbruger RA Kaslow CL Karp SA Strathdee D Vlahov, et al. 2004 Cytotoxic T-lymphocyte antigen 4 gene and recovery from hepatitis B virus infection J Virol 78 11258 11262 15452244 10.1128/JVI.78.20.11258-11262.2004 1:CAS:528:DC%2BD2cXotlKis7g%3D (Pubitemid 39299664)
29. Duan S, Zhang G, Han Q, Li Z, Liu Z, Chen J, et al. CTLA-4 exon 1 +49 polymorphism alone and in a haplotype with -318 promoter polymorphism may confer susceptibility to chronic HBV infection in Chinese Han patients. Mol Biol Rep. 2010; DOI: 10.1007/s11033-010-0660-7.
30. Chinese Medical Association 2000 Infectious and Parasitic Diseases Branch and Hepatology Branch. Viral hepatitis prevention and treatment guidelines Chin J Hepatol 8 324 329
31. Chinese Anticancer Society of Hepatoma Professional Board 2001 The clinical diagnosis and staging criteria of primary hepatic carcinoma Chin J Hepatol 9 324
32. Li Z, Zhang Z, He Z, Tang W, Li T, Zeng Z, et al. A partition-ligation- combination-subdivision EM algorithm for haplotype inference with multiallelic markers: update of the SHEsis ( http://analysis.bio-x.cn ). Cell Res. 2009;19:519-23.
33. DV Zaykin PH Westfall SS Young MA Karnoub MJ Wagner MG Ehm 2002 Testing association of statistically inferred haplotypes with discrete and continuous traits in samples of unrelated individuals Hum Hered 53 79 91 12037407 10.1159/000057986 (Pubitemid 34621657)
34. K Borucki C Weikert E Fisher S Jakubiczka C Luley S Westphal, et al. 2009 Haplotypes in the UGT1A1 gene and their role as genetic determinants of bilirubin concentration in healthy German volunteers Clin Biochem 42 1635 1641 19732760 10.1016/j.clinbiochem.2009.08.011 1:CAS:528:DC%2BD1MXht1CqsrfJ
35. N Sheron J Lau H Daniels J Goka A Eddleston GJ Alexander, et al. 1991 Increased production of tumour necrosis factor alpha in chronic hepatitis B virus infection J Hepatol 12 241 245 2051003 10.1016/0168-8278(91)90945-8 1:STN:280:DyaK3M3mvVCqsg%3D%3D
36. V Barnaba A Franco M Paroli R Benvenuto G De Petrillo VL Burgio, et al. 1994 Selective expansion of cytotoxic T lymphocytes with a CD4+CD56+ surface phenotype and a T helper type 1 profile of cytokine secretion in the liver of patients chronically infected with Hepatitis B virus J Immunol 152 3074 3087 7511637 1:CAS:528:DyaK2cXis1Oqurc%3D
37. H Tilg A Wilmer W Vogel M Herold B Nölchen G Judmaier, et al. 1992 Serum levels of cytokines in chronic liver diseases Gastroenterology 103 264 274 1612333 1:CAS:528:DyaK38XkvVOrt7s%3D
38. LG Guidotti T Ishikawa MV Hobbs B Matzke R Schreiber FV Chisari 1996 Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes Immunity 4 25 36 8574849 10.1016/S1074-7613(00)80295-2 1:CAS:528: DyaK28Xos1Kltw%3D%3D (Pubitemid 26054933)
39. S Phillips S Chokshi A Riva A Evans R Williams NV Naoumov 2010 CD8(+) T cell control of hepatitis B virus replication: direct comparison between cytolytic and noncytolytic functions J Immunol 184 287 295 19949099 10.4049/jimmunol.0902761 1:CAS:528:DC%2BD1MXhsFOnsLjL
40. A Bertoletti MM D'Elios C Boni M De Carli AL Zignego M Durazzo, et al. 1997 Different cytokine profiles of intraphepatic T cells in chronic hepatitis B and hepatitis C virus infections Gastroenterology 112 193 199 8978359 10.1016/S0016-5085(97)70235-X 1:STN:280:DyaK2s7jtlSjsg%3D%3D (Pubitemid 27009002)
41. Z Jiang X Feng W Zhang F Gao Q Ling L Zhou, et al. 2007 Recipient cytotoxic T lymphocyte antigen-4 +49 G/G genotype is associated with reduced incidence of hepatitis B virus recurrence after liver transplantation among Chinese patients Liver Int 27 1202 1208 17919231 1:CAS:528:DC%2BD2sXhtlalu7jI (Pubitemid 47543148)
42. T Kouki Y Sawai CA Gardine ME Fisfalen ML Alegre LJ DeGroot 2000 CTLA-4 gene polymorphism at position 49 in exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of Graves' disease J Immunol 165 6606 6611 11086105 1:CAS:528:DC%2BD3cXosFOhtr4%3D
43. DC Crawford DA Nickerson 2005 Definition and clinical importance of haplotypes Annu Rev Med 56 303 320 15660514 10.1146/annurev.med.56.082103.104540 1:CAS:528:DC%2BD2MXisVSrsbc%3D (Pubitemid 40299785)
44. VC Sandrim JE Tanus-Santos 2007 Haplotype analysis can provide improved clinical information than single genotype analysis Thromb Res 120 779 17174381 10.1016/j.thromres.2006.08.013 1:CAS:528:DC%2BD2sXpsFKrt7k%3D (Pubitemid 47268038)
45. H Ueda JM Howson L Esposito J Heward H Snook G Chamberlain, et al. 2003 Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease Nature 423 506 511 12724780 10.1038/nature01621 1:CAS:528:DC%2BD3sXktVygtLk%3D (Pubitemid 36648570)
46. PM Holopainen JA Partanen 2001 Technical note: linkage disequilibrium and disease-associated CTLA4 gene polymorphisms J Immunol 167 2457 2458 11509583 1:CAS:528:DC%2BD3MXmtlSjsb4%3D (Pubitemid 32768870)